Circulating Tumor DNA in Endometrial Cancer
About this study
The goal of this study is to identify circulating tumor DNA in the preoperative blood samples of endometrial cancer patients and detect changes in the quantity and tumor-specific mutations and chromosomal rearrangements in circulating tumor DNA of patients with endometrial cancer.
Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. If you need assistance understanding the eligibility criteria, please contact the study team.See eligibility criteria
- Women with a pathologic diagnosis of endometrial cancer
- Able to provide informed consent.
Participating Mayo Clinic locations
Study statuses change often. Please contact us for help.